Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drugs in pill cap Plan designs pushing lower-cost options and targeted adherence interventions helped to drive a higher compliance rate among patients who kept taking medications. (Photo: Shutterstock)

Patients did better in sticking with their prescription drug regimens during 2017, with strategies including greater use of generics helping to keep their spending down.

According to CVS Health’s 2017 Drug Trend Report, lowering the costs of common drugs helped people to stick with their drug regimens last year, reaching the highest level of compliance in seven years. In addition, strategy changes led to smaller price increases and lower spending on pharmacy benefit plans for payor clients.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO
Live Chat

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.